The Discounted Cash Flow (DCF) valuation of Biofermin Pharmaceutical Co Ltd (4517.T) is 4,188.04 JPY. With the latest stock price at 3,130.00 JPY, the upside of Biofermin Pharmaceutical Co Ltd based on DCF is 33.8%.
Based on the latest price of 3,130.00 JPY and our DCF valuation, Biofermin Pharmaceutical Co Ltd (4517.T) is a buy. buying 4517.T stocks now will result in a potential gain of 33.8%.
| Range | Selected | |
| WACC / Discount Rate | 4.6% - 6.7% | 5.6% |
| Long-term Growth Rate | 0.5% - 1.5% | 1.0% |
| Fair Price | 3,492.64 - 5,578.75 | 4,188.04 |
| Upside | 11.6% - 78.2% | 33.8% |